# Study in Healthy Volunteers of the Reversion by Haemostatic Drugs of the Anticoagulant Effect of New Anti-thrombotics

> **NCT01210755** · PHASE4 · COMPLETED · sponsor: **University Hospital, Grenoble** · enrollment: 10 (estimated)

## Conditions studied

- Venous Thromboembolism

## Interventions

- **DRUG:** Rivaroxaban, Dabigatran
- **DRUG:** Dabigatran; Rivaroxaban

## Key facts

- **NCT ID:** NCT01210755
- **Lead sponsor:** University Hospital, Grenoble
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-11
- **Primary completion:** 2011-03
- **Final completion:** 2011-06
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2011-07-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01210755

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01210755, "Study in Healthy Volunteers of the Reversion by Haemostatic Drugs of the Anticoagulant Effect of New Anti-thrombotics". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01210755. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*